Widely read:
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we would like to inform you that the Board of the Company at its meeting held today i.e. on 15 July 2026 inter-alia has considered and approved the following:1. Unaudited Financial Results (Consolidated & Standalone) for the quarter ended 30 June 2026 is enclosed as Annexure-I.2. Capex of Rs 128 Crores for expanding the capacity to manufacture Anthraquinone and Carbazole from 2600 MTPA to 5300 MTPA. 3. Capex of Rs. 70 Crores for setting up Indias First manufacturing facility of Carbon Nano Tubes (CNT) in West Bengal with In-house developed technology. 4. Capex of Rs. 170 Crores for manufacturing of Super Speciality Carbon Black.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
